Expression of peroxisome proliferator-activated receptors in human testicular cancer and growth inhibition by its agonists

Urology

Volumn 60, Issue 3, 2002, Pages 542-547

  Hase, Taro ^a   Yoshimura, Rikio ^a,c   Mitsuhashi, Makoto ^a   Segawa, Yoshihiro ^a   Kawahito, Yutaka ^b   Wada, Seiji ^a   Nakatani, Tatsuya ^a   Sano, Hajime ^b  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; UNCLASSIFIED DRUG;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TESTIS CARCINOMA;

EID: 0036754728     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)01747-8     Document Type: Article

References (24)

1. Weidner N., Folkman J., Pozza F., et al. Tumor angiogenesis a new significant and independent prognostic indicator in early stage breast carcinoma . J Natl Cancer Inst. 84:1992;1875-1887.
2. Lafyatis R., Thompson N.L., Remmers E.F., et al. Transforming growth factor-beta production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritic rats studies on secretion by synovial fibroblast-like cells and immunohistologic localization . J Immunol. 143:1989;1142-1148.
3. Kubota T., Koshizuka K., Williamson E.A., et al. Ligand for peroxisome proliferator-activated receptor-γ (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res. 58:1998;3344-3352.
4. Spiegelman B.M. PPAR-gamma adipogenic regulator and thiazolidinedione receptor . Diabetes. 47:1998;507-514.
5. Mueller E., Sarraf P., Tontonoz P., et al. Terminal differentiation of human breast cancer through PPAR gamma. Mol Cell. 1:1998;465-470.
6. Sarraf P., Mueller E., Jones D., et al. Differentiation and reversal of malignant changes in colon cancer through PPAR gamma. Nat Med. 4:1998;1046-1052.
7. Chang T.H., Szabo E. Ligands for peroxisome proliferator-activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Cancer Res. 60:2000;1129-1138.
8. Elstner E., Muller C., Koshizuka K., et al. Ligands for peroxisome proliferator-activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc Natl Acad Sci USA. 95:1998;8806-8811.
9. Braissant O., Foufelle F., Scotto C., et al. Differential expression of peroxisome proliferator-activated receptors (PPARs) tissue distribution of PPAR-α, -β and -γ in the adult rat . Endocrinology. 137:1996;354-366.
10. Hunter J., Kassam A., Winrow C.J., et al. Crosstalk between the thyroid hormone and peroxisome proliferator-activated receptors in regulating peroxisome proliferator-responsive genes. Mol Cell Endocrinol. 116:1996;213-221.
11. Aubeouf D., Rieusset J., Fajas L., et al. Tissue distribution and quantification of expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor in humans. Diabetes. 46:1997;1319-1327.
12. Sano H., Engleka K., Mathern P., et al. Coexpression of platelet-derived growth factor-B, and fibroblast growth factor-1 in situ in synovial tissues of patients with rheumatoid arthritis and Lewis rats with adjuvant or streptococcal cell wall arthritis. J Clin Invest. 91:1993;553-565.
13. Kujubu D.A., Reddy S.T., Fletcher B.S., et al. Expression of the protein product of the prostaglandin synthase-2/TIS10 gene in mitogen-stimulated Swiss 3T3 cells. J Biol Chem. 268:1993;5425-5430.
14. Fitzgerald S.M., Flinn S. Evaluating research studies using the analysis of variance (ANOVA) issues and interpretations . J Hand Ther. 13:2000;56-60.
15. Braissant O., Foufelle F., Scotto C., et al. Differential expression of peroxisome proliferator-activated receptors (PPARs) tissue distribution of PPAR- and- in the adult rat . Endocrinology. 137:1996;354-356.
16. Motomura W., Okumura T., Takahashi N., et al. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human pancreatic carcinoma cells. Cancer Res. 60:2000;5558-5564.
17. Kubota T., Koshizuka K., Williamson E.A., et al. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res. 58:1998;3344-3352.
18. Takahashi N., Okumura T., Motomura W., et al. Activation of PPAR gamma inhibits cell growth and induces apoptosis in human gastric cancer cells. FEBS Lett. 455:1999;135-139.
19. Tsubouchi Y., Sano H., Kawahito Y., et al. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor gamma agonists through induction of apoptosis. Biochem Biophys Res Commun. 270:2000;400-405.
20. Lemberger T., Saladin R., Vazquez M., et al. Expression of peroxisome proliferator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythm. J Biol Chem. 271:1996;1764-1769.
21. Bishop-Bailey D., Hla T. Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-delta 12, 14-prostaglandin J2. J Biol Chem. 274:1999;17042-17048.
22. Mueller E., Sarraf P., Tontonz P., et al. Terminal differentiation of human breast cancer through PPAR-γ Mol Cell. 1:1998;465-470.
23. Takahashi N., Okumura T., Motomura W., et al. Activation of PPAR gamma inhibits cell growth and induces apoptosis in human gastric cancer cells. FEBS Lett. 455:1999;135-139.
24. Brockman J.A., Gupta R.A., DuBois R.N. Activation of PPAR gamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology. 115:1998;1049-1055.